Vaccine containing the three allelic variants of the Plasmodium vivax circumsporozoite antigen induces protection in mice after challenge with a transgenic rodent Malaria parasite..

Plasmodium vivax is the most common species that cause malaria outside of the African continent. The development of an efficacious vaccine would contribute greatly to control malaria. Recently, using bacterial and adenoviral recombinant proteins based on the P. vivax circumsporozoite protein (CSP),...

Descripció completa

Dades bibliogràfiques
Autors principals: Gimenez, A, Lima, L, Françoso, K, Denapoli, P, Panatieri, R, Bargieri, D, Thiberge, J, Andolina, C, Nosten, F, Renia, L, Nussenzweig, R, Nussenzweig, V, Amino, R, Rodrigues, M, Soares, I
Format: Journal article
Idioma:English
Publicat: Frontiers Media 2017

Ítems similars